(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) 2021 ´ëÇѺñ¸¸ÇÐȸ Á¦53Â÷ Ãá°èÇмú´ëȸ_3/26 : 2021-03-26±³À°ÀÏÀÚ : 2021-03-26
±³À°Àå¼Ò : ¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ (*¿ÀÇÁ¶óÀÎ: ½¦¶óÅæ ¼¿ï µðÅ¥ºê½ÃƼ È£ÅÚ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) 2021 ´ëÇѺñ¸¸ÇÐȸ Á¦53Â÷ Ãá°èÇмú´ëȸ_3/26 ÁÖÃÖ±â°ü : ´ëÇѺñ¸¸ÇÐȸ
´ã´çÀÚ : ¾ÈÇýÀº
¿¬¶ôó : 02-6941-0888
À̸ÞÀÏ :
obesity@kosso.or.kr ±³À°Á¾·ù : ³»°ú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 26ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 17:30~18:00 The importance of personalized treatment for type 2 diabetic ¹Ú¼¼Àº(¼º±Õ°üÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03¿ù 26ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 18:00~18:30 Treating benefits of Duvie for Korean T2DM patients ±è°æ¼ö(Â÷ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03¿ù 26ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 18:30~19:00 Obesity treatment strategy in the COVID-19 environment : Focus on Phentermine/Topiramate combination °ÁöÇö(°Ç¾çÀÇ´ë °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 03¿ù 26ÀÏ ¶óº¥´õ 17:30~18:10 The importance of glucose monitoring for weight control ÀÓ¼ö(¼¿ïÀÇ´ë ºÐ´ç¼¿ï´ëº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03¿ù 26ÀÏ ¶óº¥´õ 18:10~18:50 Dapagliflozin¡¯s glucose control with HF and Renal benefit È«ÁØÈ(À»ÁöÀÇ´ë)
±³À°½Ã°£ 03¿ù 26ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 19:10~19:40 The short-term effects of angiotensin II receptor blockers on albuminuria and renal function in Korean patients ±èÇ强(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø ³»ºÐºñ³»°ú)